BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Helsinn, Otsuka Holdings deal

Helsinn granted Otsuka's Taiho Pharmaceutical Co. Ltd. subsidiary a license in Japan to develop and commercialize oral and IV forms of Netu-palo-FDC to prevent chemotherapy-induced nausea and vomiting (CINV). Under the deal, Taiho will be...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >